Skip to content

SION SION Convertible Preferred Stock Authorized Shares

Convertible Preferred Stock Authorized Shares at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
5M0.0%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
40M0.0%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's convertible preferred stock authorized shares.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's convertible preferred stock authorized shares?
SION (SION) reported convertible preferred stock authorized shares of 10M in Q1 2026.
How has SION's convertible preferred stock authorized shares changed year-over-year?
SION's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 10M to 10M.
What does convertible preferred stock authorized shares mean?
Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.